Observation of the effect of early warning score in the treatment of childhood dwarfism with growth hormone
生长激素治疗小儿矮小症中应用儿童早期预警评分的效果观察

摘要

目的 明确生长激素治疗小儿矮小症中应用儿童早期预警评分的效果。方法 研究纳入2023.02-2024.02中综合临床各项检查结果满足小儿矮小症诊断标准的68例患者，对各个患者进行随机编号后采取随机抽取法安排为两组，对照组与观察组分别35、33例患者，对照组行常规干预，观察组行儿童早期预警评分干预，对不同干预效果进行比较分析。结果 干预后观察组总不良事件例数占比更少，P值结果<0.05，统计学差异大。干预后观察组临床指标各数据值更高，P值结果<0.05，统计学差异大。结论 于小儿矮小症患者接受生长激素治疗中应用儿童早期预警评分，有利于减少不良事件风险，改善临床指标。

Abstract

Objective: To clarify the effect of using early warning scores in the treatment of pediatric dwarfism with growth hormone. Method: A total of 68 patients who met the diagnostic criteria for pediatric dwarfism based on comprehensive clinical examination results from February 2023 to February 2024 were included in the study. After random numbering, each patient was randomly assigned to two groups: a control group with 35 patients and an observation group with 33 patients. The control group received routine intervention, while the observation group received early childhood warning score intervention. The effects of different interventions were compared and analyzed. After the intervention, the proportion of total adverse events in the observation group was lower, with a P-value of<0.05, indicating a significant statistical difference. After intervention, the clinical indicators in the observation group had higher values, with P values<0.05, indicating a significant statistical difference.
Conclusion  : The application of early childhood warning scores in growth hormone therapy for children with dwarfism is beneficial in reducing the risk of adverse events and improving clinical indicators.